MwanzoAIM • NYSEAMERICAN
add
AIM ImmunoTech Inc
$ 2.59
Baada ya Saa za Kazi:(0.39%)+0.010
$ 2.60
Imefungwa: 12 Sep, 17:07:01 GMT -4 · USD · NYSEAMERICAN · Kanusho
Bei iliyotangulia
$ 2.59
Bei za siku
$ 2.53 - $ 2.67
Bei za mwaka
$ 2.33 - $ 20.35
Thamani ya kampuni katika soko
7.02M USD
Wastani wa hisa zilizouzwa
elfu 77.89
Uwiano wa bei na mapato
-
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 25.00 | -50.00% |
Matumizi ya uendeshaji wa biashara | 2.66M | -28.77% |
Mapato halisi | -2.79M | -52.18% |
Kiwango cha faida halisi | elfu -11.18 | -204.36% |
Mapato kwa kila hisa | -3.68 | -22.67% |
EBITDA | -2.59M | 28.68% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | elfu 835.00 | -91.70% |
Jumla ya mali | 4.13M | -73.73% |
Jumla ya dhima | 10.68M | 11.05% |
Jumla ya hisa | -6.55M | — |
hisa zilizosalia | 2.71M | — |
Uwiano wa bei na thamani | -0.30 | — |
Faida inayotokana na mali | -127.49% | — |
Faida inayotokana mtaji | 260.64% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -2.79M | -52.18% |
Pesa kutokana na shughuli | -1.53M | 49.10% |
Pesa kutokana na uwekezaji | elfu 754.00 | -8.72% |
Pesa kutokana na ufadhili | elfu 355.00 | -85.46% |
Mabadiliko halisi ya pesa taslimu | elfu -422.00 | -262.93% |
Mtiririko huru wa pesa | -1.37M | 65.91% |
Kuhusu
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Ilianzishwa
1966
Makao Makuu
Tovuti
Wafanyakazi
22
